Subscribe

 

Monday, October 26, 2020

The Lankenau Institute for Medical Research (LIMR) hosts the 4th International Conference on Immunochemotherapy

Hellenic News
Hellenic Newshttps://www.hellenicnews.com
The copyrights for these articles are owned by HNA. They may not be redistributed without the permission of the owner. The opinions expressed by our authors do not necessarily reflect the opinions of HNA and its representatives.

Latest articles

Afternoon tea in the age of Coronavirus

By Aurelia Mozart’s Piano Symphony 21 is playing on my favorite internet radio station, “Beautiful Classical Music from Venice,” the kettle is rapidly boiling, a...

Εκσυγχρονισμός ή εκτροχιασμός…

«Η Ελλάδα, λέει το γνωστό εμβατήριο, ποτέ δεν πεθαίνει». Σωστά. Είναι αδύνατο να πεθάνει ένας πεθαμένος. Το στοίχημα είναι πώς θα την αναστήσουμε και...

AHEPA welcomes bipartisan outcry on Turkey’s reported missile system test

AHEPA welcomes bipartisan calls from Congress's leaders on foreign policymaking for the Administration to take action on Turkey due to Turkey's reported test of...

Trump’s Lust for Money Invigorates Turkish Aggression

By Dr. Evaggelos Vallianatos Why European leaders are afraid of Turkey NATO officials hesitate to criticize Turkey, much less contemplate policies teaching this Moslem country...

Syracuse AHEPA Chapter 37 Celebrates OXI Day

By: Michael Labatos  Syracuse AHEPA Chapter 37 held their monthly meeting on October 17, 2020 virtually via GoToMeeting due to the COVID-19 pandemic. This...

AHEPA Chapter #64 Volunteers for Holy Trinity Community Drive-Thru Fundraiser in Harrisburg

By Dr. Michael Billys GYRO DRIVE-THRU took place twice on Fridays and Saturdays, (September 18th and 19th and October 16th and 17th) from 11 am – 7...

ΓΕΝΟΚΤΟΝΙΕΣ – Οι “Νυρεμβέργες” που δεν έγιναν ποτέ!

Γενοκτονίες, σφαγές, βιασμοί, καταστροφή πολιτιστικών  θησαυρών. Τοποθετήσεις παγκόσμιων προσωπικοτήτων: Victor Hugo, William Gladstone, F.M. Dostoevsky, Georges Clemenceau, Winston Churchill. Γράφει ο Νικόλαος Λ. Μωραΐτης, Ph.D. Δεν υπάρχουν αρκετά δυνατές...

For Immediate Release

 

(Wynnewood, PA, April 17, 2015) – All eyes are on Philadelphia as it prepares to welcome the world’s foremost cancer researchers for the American Association of Cancer Research’s annual meeting, but, just west of city limits, Lankenau Institute for Medical Research (LIMR) is concluding a two-day conference on the rapidly expanding field of cancer immunochemotherapy.

 

LIMR, part of Main Line Health and located at Lankenau Medical Center, was selected as the host for the 4th International Conference on Immunochemotherapy, an event that welcomes cancer scientists and researchers from across the world. Guest speakers at this year’s conference included representatives from Dana Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, University of Paris Rene Descartes, and National Health Research Institute in Taiwan.

Thanks for reading Hellenic News of America

LIMR President George Prendergast, PhD, says Lankenau was an ideal location for the annual meeting because of its early work in immunochemotherapy. More than a decade ago, LIMR researchers uncovered IDO1 inhibitors, drugs that disrupt the process by which tumors evade a patient’s immune system.

 

“Immunochemotherapy is a very exciting area of research, and one that we have been heavily involved in for more than a decade,” says Dr. Prendergast. “The future of cancer treatment will increasingly focus on how to harness a patient’s immune system to combat cancer.”

 

That future, says Prendergast, begins now. The first forays of the new immunochemotherapy regimens in clinical trials are currently being offered to cancer patients, and this week’s conference has highlighted exciting new areas of research.

 

“We’re learning and we’re building on each discovery. These conferences are crucial for collaboration and advancing the field of immunochemotherapy, and LIMR and Main Line Health are  proud to have a continuing role in such an exciting field.”

 

About the Lankenau Institute for Medical Research

The mission of the Lankenau Institute for Medical Research, which is part of Main Line Health, is to advance human health and well-being through research to improve the detection and treatment of disease; the rapid transfer of new technology to the clinic; and the training of the next generation of scientists and physicians.

 

Founded in 1927, our rich history, staff of over 120, and hard working board of trustees allows us to continue our commitment to advancing an understanding of the causes of cancer, cardiovascular disease and diabetes. Located on the campus of Lankenau Medical Center, our scientists perform basic research studies to understand the fundamental problems associated with disease; preclinical and translational research where results are developed into new diagnostics or medications; and clinical research where advances in medicine can be brought to the patient bedside.

 

Photo Caption: (from left to right) Speakers at the 4th International Conference on Immunochemotherapy, hosted at Lankenau Medical Center, Laurence Zitvogel, MD, PhD, of Gustave Roussy; George Prendergast, PhD, President of LIMR; Guido Kroemer, MD, PhD, of University of Paris Rene Descartes.

The copyrights for these articles are owned by the Hellenic News of America. They may not be redistributed without the permission of the owner. The opinions expressed by our authors do not necessarily reflect the opinions of the Hellenic News of America and its representatives.

Latest Print Edition